Automated Nucleic Acid Purification Systems

Automated Nucleic Acid Purification Systems Market Outlook

The global Automated Nucleic Acid Purification Systems market is expected to reach USD 1.2 billion by 2035, growing at a CAGR of 8.5% from 2025 to 2035. This significant growth can be attributed to the increasing demand for accurate diagnostic tests and advanced research techniques in genomics and biotechnology. Factors contributing to this market expansion include the rising prevalence of genetic disorders, advancements in molecular biology technologies, and the burgeoning interest in personalized medicine. Additionally, the rapid growth of the biopharmaceutical and biotechnology sectors is further propelling the need for efficient and automated nucleic acid purification processes. Furthermore, the ongoing innovation in purification technologies is making these systems more accessible and user-friendly, fostering broader adoption in laboratories and clinical settings.

Growth Factor of the Market

The growth of the Automated Nucleic Acid Purification Systems market is significantly driven by the increasing focus on precision medicine, which demands high-quality nucleic acid isolation for effective diagnosis and treatment. The rise in research funding, particularly in genomics and proteomics, has fueled investments in automated systems that enhance throughput and reduce human error in nucleic acid extraction. Furthermore, the COVID-19 pandemic highlighted the necessity for rapid and reliable testing methods, leading to heightened awareness and adoption of automated purification technologies in diagnostics. This shift is complemented by advancing automation technologies that offer greater efficiency and ease of use, thereby enhancing laboratory productivity. Additionally, the increasing prevalence of infectious diseases and genetic disorders is pushing healthcare providers and researchers to invest in advanced nucleic acid purification systems for accurate and timely results.

Key Highlights of the Market

• Rapid technological advancements in nucleic acid purification systems, enhancing efficiency and reliability.
• Growing demand for personalized medicine driving the need for high-quality nucleic acid extraction solutions.
• Increased funding in genomics research, resulting in higher adoption of automated systems in laboratories.
• Expansion of the biopharmaceutical sector, creating a robust market for nucleic acid purification technologies.
• Heightened awareness and adoption of automated purification methods propelled by the COVID-19 pandemic.

By Product Type

Automated Benchtop Systems:

Automated Benchtop Systems are compact and user-friendly nucleic acid purification solutions designed for laboratories with limited space. These systems are capable of high-throughput processing and are ideal for small to medium-sized laboratories that require efficient nucleic acid extraction without the need for extensive manual intervention. The rising demand for molecular diagnostics is pushing the growth of this segment, as these devices can streamline processes and reduce turnaround time in nucleic acid purification. As a result, benchtop systems are becoming increasingly popular in research institutions and clinical laboratories looking to enhance their operational capabilities.

Automated Free-Standing Systems:

Automated Free-Standing Systems offer greater processing capabilities and handling of larger sample volumes compared to benchtop systems. These systems are well-suited for high-throughput laboratories, such as biopharmaceutical companies and large research facilities, where efficiency and scalability are critical. Their design allows for the simultaneous purification of multiple samples, significantly reducing the time required for nucleic acid extraction. Moreover, advancements in automation and software integration are making these systems more appealing, as they can be easily integrated into existing laboratory workflows to maximize productivity.

Automated Integrated Systems:

Automated Integrated Systems combine multiple laboratory processes, such as sample preparation and analysis, into a single platform. This comprehensive approach allows for seamless operations and improves overall workflow efficiency in laboratories. By integrating nucleic acid purification with downstream applications, these systems minimize sample handling, thereby reducing the risk of contamination and errors. The demand for integrated solutions is increasing as laboratories look for ways to optimize their operations and streamline processes, leading to enhanced productivity and cost savings.

Automated Cartridge-based Systems:

Automated Cartridge-based Systems simplify the nucleic acid purification process by utilizing pre-packaged cartridges with integrated purification reagents. These systems are designed for ease of use, requiring minimal user intervention and reducing the potential for human error. The convenience and reliability of cartridge-based systems are appealing to various end-users, including clinical laboratories and research facilities. As the importance of standardized procedures and reproducibility in nucleic acid extraction becomes more recognized, the adoption of cartridge-based systems is projected to increase significantly.

Automated Magnetic Bead Systems:

Automated Magnetic Bead Systems employ magnetic beads to facilitate the isolation of nucleic acids from complex biological samples. This technology is becoming increasingly popular due to its effectiveness in purifying nucleic acids with high yield and purity. The growing interest in advanced molecular diagnostics and genomics research is propelling the demand for magnetic bead systems, as they provide a reliable and reproducible method for nucleic acid extraction. Additionally, improvements in magnetic bead formulations and automation technology are driving innovations in this segment, making it an attractive option for laboratories aiming to enhance their purification processes.

By Application

Genomic DNA Purification:

Genomic DNA Purification is a critical application of automated nucleic acid purification systems, as it plays a vital role in various research fields, including genetics, forensics, and clinical diagnostics. The ability to extract high-quality genomic DNA rapidly and efficiently is essential for downstream applications such as sequencing, genotyping, and PCR analysis. The increasing emphasis on genetic research and the growing prevalence of genetic disorders are driving the demand for genomic DNA purification systems. Additionally, advancements in extraction technologies are enabling higher yields and improved purity, further solidifying the importance of this application in the market.

Plasmid DNA Purification:

Plasmid DNA Purification is paramount in biotechnology and genetic engineering, particularly in the production of recombinant proteins and gene therapy applications. Automated systems designed specifically for plasmid DNA purification streamline the extraction process, allowing for high-throughput processing and consistent results. The increasing focus on biopharmaceutical development and the need for reliable plasmid DNA for various applications are driving the growth of this segment. Furthermore, the advancements in purification techniques are enabling enhanced plasmid yields and purity, which are crucial for successful downstream applications.

RNA Purification:

RNA Purification is a critical component of molecular biology research, especially in the context of gene expression studies and RNA sequencing applications. Automated nucleic acid purification systems designed for RNA extraction highlight the importance of obtaining high-quality RNA for accurate analysis. The growing interest in transcriptomics and the increasing prevalence of RNA-based therapeutics are propelling demand for RNA purification systems. Moreover, advancements in purification technologies that minimize RNA degradation during extraction are fostering the growth of this application segment, making it an essential focus for researchers.

miRNA Purification:

miRNA Purification is becoming increasingly important as microRNAs play a crucial role in gene regulation and have been implicated in various diseases. Automated systems that specialize in miRNA extraction facilitate the isolation of small RNA species, allowing for comprehensive analysis of miRNA profiles in different biological samples. The growing recognition of miRNAs as potential biomarkers for disease diagnosis and prognosis is driving the demand for specialized purification systems. As research in this field expands, the need for reliable and efficient miRNA purification methods will continue to grow, further enhancing this application segment.

Total Nucleic Acid Purification:

Total Nucleic Acid Purification encompasses the extraction of both DNA and RNA from biological samples, making it a versatile application in molecular diagnostics and research. Automated systems that offer total nucleic acid purification capabilities are especially beneficial for laboratories that require flexibility in their workflows. The increasing demand for comprehensive nucleic acid analysis in various fields, including clinical diagnostics and environmental monitoring, is driving the adoption of total nucleic acid purification systems. Additionally, advancements in purification technologies that allow for simultaneous extraction of DNA and RNA are expected to propel the growth of this application segment.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for automated nucleic acid purification systems, primarily due to their critical role in patient diagnostics and treatment. The rising demand for molecular diagnostics in clinical settings is driving hospitals to invest in advanced purification technologies that allow for rapid and accurate nucleic acid extraction. Automated systems not only enhance laboratory efficiency but also improve turnaround times for diagnostic results, which is essential for timely patient care. As hospitals increasingly adopt personalized medicine approaches, the demand for reliable nucleic acid purification systems is expected to continue growing in this sector.

Diagnostic Laboratories:

Diagnostic Laboratories are key players in the distribution of automated nucleic acid purification systems, as they serve as the frontline for medical testing and diagnostics. The need for high-throughput and reliable nucleic acid extraction processes is paramount in these laboratories, where accuracy and speed are critical. Automated purification systems enable diagnostic labs to handle large volumes of samples efficiently, thereby increasing their operational capabilities. As the demand for molecular testing continues to rise, driven by advancements in genomics and personalized medicine, diagnostic laboratories are likely to increasingly invest in automated purification technologies.

Research Institutes:

Research Institutes are pivotal in driving innovation and development in nucleic acid purification technologies. These institutions have a vast array of applications, ranging from basic research to applied sciences, necessitating robust and efficient purification systems. Automated nucleic acid purification systems offer researchers the ability to obtain high-quality nucleic acids with minimal hands-on time, thereby allowing them to focus on their core research activities. As funding for research in genomics and proteomics continues to grow, research institutes are expected to be significant adopters of automated purification systems to facilitate their studies.

Biopharmaceutical Companies:

Biopharmaceutical Companies require reliable nucleic acid purification systems for various applications, including drug development, vaccine production, and genetic engineering. The demand for high-quality nucleic acids is crucial in the biopharmaceutical industry, where the success of therapeutic products often hinges on the integrity and purity of the nucleic acids used. Automated systems help streamline processes and ensure consistency in nucleic acid extraction, which is vital in meeting regulatory standards. As the industry continues to evolve, biopharmaceutical companies will increasingly rely on advanced purification systems to support their research and production activities.

By Technology

Magnetic Bead Technology:

Magnetic Bead Technology is widely recognized for its efficiency in nucleic acid purification. This technology utilizes magnetic beads coated with specific binding agents that selectively capture nucleic acids from complex samples. The process is automated, reducing the need for manual intervention and ensuring consistent results. With the increasing demand for high-throughput nucleic acid extraction, magnetic bead technology is gaining traction in both clinical and research laboratories. Additionally, advancements in bead formulations are enhancing the specificity and yield of nucleic acid isolation, further solidifying its position in the market.

Silica Membrane Technology:

Silica Membrane Technology is a popular method for nucleic acid purification due to its simplicity and effectiveness. This technology employs silica membranes that selectively bind nucleic acids under specific conditions, allowing for efficient extraction from various sample types. The growing need for reliable and reproducible nucleic acid extraction methods in both research and clinical settings is driving the adoption of silica membrane technology. Furthermore, innovations in membrane design and chemistry are improving the performance of this technology, making it a preferred choice for many laboratories.

Anion-exchange Technology:

Anion-exchange Technology involves the use of charged resins to isolate nucleic acids based on their charge properties. This method offers high specificity and yield, making it suitable for applications requiring high-purity nucleic acids. The technology is widely used in research and biopharmaceutical settings where purity and integrity are paramount. As the demand for high-quality nucleic acids in molecular diagnostics and therapeutic development continues to grow, anion-exchange technology is expected to gain popularity among researchers and industry professionals alike.

Solid Phase Extraction Technology:

Solid Phase Extraction Technology is employed for the purification of nucleic acids through the use of solid sorbent materials. This method allows for the efficient separation of nucleic acids from contaminants, resulting in high-quality extracts suitable for downstream applications. The versatility and adaptability of solid-phase extraction make it a valuable technique in various research areas, including environmental monitoring and clinical diagnostics. As the need for efficient purification methods increases, solid-phase extraction technology is likely to see continued growth in the Automated Nucleic Acid Purification Systems market.

Differential Precipitation Technology:

Differential Precipitation Technology utilizes selective precipitation methods to isolate nucleic acids from biological samples. This technology offers an alternative approach to traditional extraction methods, providing researchers with additional options for nucleic acid purification. The ability to selectively precipitate nucleic acids while removing impurities makes this technology attractive for specific applications in molecular biology. As research in nucleic acid analysis expands, the demand for diverse purification methodologies, including differential precipitation, is expected to grow within the market.

By Region

The North American region holds a dominant share of the Automated Nucleic Acid Purification Systems market, driven by the presence of leading biopharmaceutical companies, advanced research institutions, and high healthcare expenditures. This region is expected to witness a CAGR of 9% from 2025 to 2035, reflecting the increasing adoption of advanced molecular diagnostic techniques and the growing focus on personalized medicine. The robust research infrastructure and favorable regulatory environment further contribute to the growth of this market in North America, as laboratories seek efficient nucleic acid purification solutions to support their research and diagnostic efforts.

Europe is another key region in the Automated Nucleic Acid Purification Systems market, characterized by a strong emphasis on genomics research and advances in biotechnology. The increasing funding in research initiatives and collaborations between academic institutions and industry players are driving the demand for automated purification systems in this region. As the importance of molecular diagnostics continues to rise, the European market is expected to witness significant growth, particularly in countries with established biopharmaceutical sectors. The overall regional demand is projected to remain robust, contributing to the global market growth.

Opportunities

The Automated Nucleic Acid Purification Systems market presents numerous opportunities for growth, particularly in emerging markets where advancements in biotechnology and healthcare are gaining momentum. As countries in the Asia Pacific region continue to invest in research and development, there is a growing need for reliable nucleic acid extraction solutions to support various applications in diagnostics and therapeutics. Furthermore, the increasing prevalence of genetic disorders and infectious diseases is driving the demand for efficient purification systems in these regions. Companies that focus on providing cost-effective and user-friendly solutions tailored to the specific needs of emerging markets will likely find significant opportunities for expansion.

Additionally, the growing trend towards personalized medicine and targeted therapies is creating opportunities for specialized nucleic acid purification systems designed to support these innovative approaches. As researchers and clinicians seek to develop more precise diagnostic tools and therapeutic interventions, the need for high-quality nucleic acid extraction will become ever more critical. Companies that innovate and develop advanced purification technologies, such as microfluidics and lab-on-a-chip systems, can capitalize on this trend and position themselves as leaders in the Automated Nucleic Acid Purification Systems market.

Threats

The Automated Nucleic Acid Purification Systems market faces several threats that could hinder its growth, including the rapid pace of technological advancements and evolving consumer preferences. As new purification technologies emerge, existing systems may become obsolete, forcing manufacturers to invest in continuous innovation to stay competitive. Furthermore, the market is characterized by increasing competition, with numerous players offering similar products, which may lead to price wars and reduced profit margins. Companies that fail to adapt to changing market trends or invest in R&D may find it challenging to maintain their market position amidst growing competition.

Another significant threat to the Automated Nucleic Acid Purification Systems market is the potential for regulatory challenges. As the industry becomes more regulated, companies must comply with stringent quality and safety standards, which can be time-consuming and costly. Any delays in product approvals or adverse regulatory changes can negatively impact market growth and hinder the entry of new players. To mitigate these threats, industry stakeholders must continuously monitor regulatory developments and invest in robust quality assurance processes to ensure compliance and maintain operational efficiency.

Competitor Outlook

• Thermo Fisher Scientific
• Qiagen
• Promega Corporation
• Merck KGaA
• Takara Bio Inc.
• Agilent Technologies
• Bio-Rad Laboratories
• NEB (New England Biolabs)
• Fisher Scientific
• Roche Diagnostics
• Zymo Research Corp.
• GenScript
• Beckman Coulter
• Horizon Discovery
• Oxford Nanopore Technologies

The competitive landscape of the Automated Nucleic Acid Purification Systems market is characterized by the presence of numerous established players and emerging innovators. Major companies are focusing on expanding their product portfolios and enhancing the capabilities of their purification systems to cater to the diverse needs of researchers and clinicians. Additionally, strategic partnerships, collaborations, and acquisitions are common trends in the industry as companies seek to strengthen their market position and leverage complementary technologies. The competitive dynamics are further influenced by factors such as pricing strategies, product quality, and customer support services, all of which play a crucial role in attracting and retaining customers in this rapidly evolving market.

Thermo Fisher Scientific, a leading player in the nucleic acid purification market, offers a wide range of automated systems designed for various applications, including clinical diagnostics and research. The company is known for its innovative technologies and commitment to quality, which enable researchers to achieve reliable results. Meanwhile, Qiagen is recognized for its expertise in sample preparation and molecular diagnostics, providing robust purification solutions that are widely adopted in both research and clinical laboratories. The company continuously invests in R&D to enhance its product offerings and meet the evolving needs of the market.

Promega Corporation is another key competitor in the Automated Nucleic Acid Purification Systems market, known for its comprehensive range of products catering to DNA, RNA, and protein purification. The company's focus on quality and performance has established it as a trusted partner in the life sciences industry. Merck KGaA and Takara Bio Inc. are also significant players that offer advanced purification technologies and solutions tailored to specific applications, further enriching the competitive landscape. With the growing emphasis on innovation and efficiency in nucleic acid extraction methods, these companies are well-positioned to capitalize on the increasing demand for automated purification systems.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Qiagen
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GenScript
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Beckman Coulter
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Takara Bio Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fisher Scientific
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Horizon Discovery
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Promega Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Zymo Research Corp.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 NEB (New England Biolabs)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Oxford Nanopore Technologies
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Automated Nucleic Acid Purification Systems Market, By Technology
    • 6.1.1 Magnetic Bead Technology
    • 6.1.2 Silica Membrane Technology
    • 6.1.3 Anion-exchange Technology
    • 6.1.4 Solid Phase Extraction Technology
    • 6.1.5 Differential Precipitation Technology
  • 6.2 Automated Nucleic Acid Purification Systems Market, By Application
    • 6.2.1 Genomic DNA Purification
    • 6.2.2 Plasmid DNA Purification
    • 6.2.3 RNA Purification
    • 6.2.4 miRNA Purification
    • 6.2.5 Total Nucleic Acid Purification
  • 6.3 Automated Nucleic Acid Purification Systems Market, By Product Type
    • 6.3.1 Automated Benchtop Systems
    • 6.3.2 Automated Free-Standing Systems
    • 6.3.3 Automated Integrated Systems
    • 6.3.4 Automated Cartridge-based Systems
    • 6.3.5 Automated Magnetic Bead Systems
  • 6.4 Automated Nucleic Acid Purification Systems Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Diagnostic Laboratories
    • 6.4.3 Research Institutes
    • 6.4.4 Biopharmaceutical Companies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Automated Nucleic Acid Purification Systems Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Automated Nucleic Acid Purification Systems market is categorized based on

By Product Type

• Automated Benchtop Systems
• Automated Free-Standing Systems
• Automated Integrated Systems
• Automated Cartridge-based Systems
• Automated Magnetic Bead Systems

By Application

• Genomic DNA Purification
• Plasmid DNA Purification
• RNA Purification
• miRNA Purification
• Total Nucleic Acid Purification

By Distribution Channel

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Biopharmaceutical Companies

By Technology

• Magnetic Bead Technology
• Silica Membrane Technology
• Anion-exchange Technology
• Solid Phase Extraction Technology
• Differential Precipitation Technology

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Qiagen
• Promega Corporation
• Merck KGaA
• Takara Bio Inc.
• Agilent Technologies
• Bio-Rad Laboratories
• NEB (New England Biolabs)
• Fisher Scientific
• Roche Diagnostics
• Zymo Research Corp.
• GenScript
• Beckman Coulter
• Horizon Discovery
• Oxford Nanopore Technologies